Ypsomed Holding AG
YPSN
Rang in Aktien
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Aktienkurs
$469.39
Marktkapitalisierung
$6.17B
Veränderung (1 Tag)
1.63%
Veränderung (1 Jahr)
18.98%
Land
CH
Handel Ypsomed Holding AG (YPSN)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Ypsomed Holding AG (YPSN)
Anzahl der ausstehenden Aktien zum October 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Ypsomed Holding AG beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von October 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Ypsomed Holding AG (YPSN) von 2002 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2025 | 13.65M | 0.00% |
| 2024 | 13.65M | 1.74% |
| 2023 | 13.42M | 5.79% |
| 2022 | 12.68M | 0.26% |
| 2021 | 12.65M | 0.07% |
| 2020 | 12.64M | 0.31% |
| 2019 | 12.60M | 0.13% |
| 2018 | 12.59M | -0.22% |
| 2017 | 12.61M | -0.09% |
| 2016 | 12.62M | 0.00% |
| 2015 | 12.62M | 0.08% |
| 2014 | 12.61M | 0.00% |
| 2013 | 12.61M | -0.31% |
| 2012 | 12.65M | -0.05% |
| 2011 | 12.66M | 5.40% |
| 2010 | 12.01M | 6.69% |
| 2009 | 11.26M | -0.08% |
| 2008 | 11.27M | 0.03% |
| 2007 | 11.26M | -0.08% |
| 2006 | 11.27M | -0.05% |
| 2005 | 11.28M | 351.15% |
| 2004 | 2.50M | -0.28% |
| 2003 | 2.51M | -77.77% |
| 2002 | 11.28M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 97.60M | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| 52.26M | - |
KR
|
